Videos

Videos

2019

EHA – (3) Part Video Series

Invivoscribe’s Symposium at EHA 2019 | Amsterdam, The Netherlands | June 13, 2019
Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.

Invivoscribe – EHA 2019 Video Series Part (1) of 3
Featured Speaker Marleen Bakkus

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
Clonality Assessment and MRD Analysis in Acute Lymphoblastic Leukemia and Multiple Myeloma Using the LymphoTrack Dx NGS Assays.
Featured Speaker: Marleen Bakkus – Laboratory for Molecular Hematology, UZ Brussel, University Hospital Brussels, Brussel, Belgium

Invivoscribe – EHA 2019 Video Series Part (2) of 3
Featured Speaker Marc Seifert

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
Analysis of Human BCR Rearrangement Repertoires in Health and Disease.
Featured Speaker: Marc Seifert – Institute of Cell Biology (Tumor Research), AG Immunology and Lymphomagenesis, Essen University Hospital, Essen, Germany

Invivoscribe – EHA 2019 Video Series Part (3) of 3
Featured Speaker Fiona Quinn

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
B- and T-Cell Clonality Analysis and CLL IGHV Mutational Status – an Overview.
Featured Speaker: Fiona Quinn – Cancer Molecular Diagnostics Dept., St. James’s Hospital, Dublin, Ireland

ASCO

Invivoscribe – ASCO 2019 LeukoStrat CDx FLT3 Mutation Assay Presentation | Chicago, IL | June 01, 2019
Featured Speaker Dr. Bradley Patay, Invivoscribe’s Chief Medical Officer Presents Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay at Chicago Firehouse Grill.

Invivoscribe – ASCO – LeukoStrat CDx FLT3 Mutation Assay
Featured Speaker Dr. Bradley Patay

Invivoscribe – ASCO – LeukoStrat CDx FLT3 Mutation Assay
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay
Featured Speaker: Dr. Bradley Patay, Invivoscribe, Chief Medical Officer

AMP GLOBAL – (4) Part Video Series

Invivoscribe – AMP Global 2019 | Hong Kong, Japan | May 16, 2019
NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.

Invivoscribe – AMP Global 2019
Video Series Part (1) of 4

Featured Speaker Bettina Budeus

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Analysis of Human BCR Rearrangement Repertoires in Health and Disease.
Featured Speaker: Bettina Budeus – Group Molecular Genetics, Essen University Hospital, Essen, Germany

Invivoscribe – AMP Global 2019
Video Series Part (2) of 4

Featured Speaker Roshanak Bob

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
A Practical Interpretation of Clonality Results, IdentiClone and LymphoTrack Assays in Daily Diagnosis.
Featured Speaker: Roshanak Bob – Berlin Reference Center for Lymphoma and Hematopathology, Berlin, Germany

Invivoscribe – AMP Global 2019
Video Series Part (3) of 4

Featured Speaker Oliver Giles Best

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Analysis of IGHV Mutational Status, T-Cell Clonality and MRD by NGS.
Featured Speaker: Oliver Giles Best – CLL Research Laboratory, Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, Australia

Invivoscribe – AMP Global 2019
Video Series Part (4) of 4

Featured Speaker Piers Blombery

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Case Studies of IGHV Analysis and NGS Mutation Detection in Lymphoid Malignancy.
Featured Speaker: Piers Blombery – Peter MacCallum Cancer Centre, Melbourne, Australia